机译:评估6-硫嘌呤毒性并通过小分子增强剂将治疗应用扩展其治疗癌症的新方法
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
Department of Chemistry Kansas State University 1212 Mid-Campus Drive North Manhattan KS 66506 USA;
New methods; assess 6-thiopurine; pancreatic cancer via small molecule potentiators;
机译:评估6-硫嘌呤毒性并通过小分子增强剂将治疗应用扩展其治疗癌症的新方法
机译:ex-体内扩增人NK细胞通过直接识别和抗体指向细胞细胞毒性介导细胞毒性和细胞因子释放对同种异体癌细胞系的释放:治疗潜在使用NK细胞用于血液和实体瘤
机译:CFTR混合位点变体的解释和分层,以鉴定小分子矫正剂和增效剂的潜在治疗靶标
机译:评估调节分子对胰腺癌患者预后的预测价值:一种计算方法
机译:在乳腺癌和胰腺癌中使用弹性蛋白样多肽的抗癌治疗药物的热靶向递送。
机译:通过小分子增强剂评估6-硫嘌呤毒性并将其在胰腺癌中的治疗应用扩展的新方法
机译:葫芦素B,一种吉西他滨的新型体内增效剂,对胰腺癌的低毒性